Menu
Search
|

Menu

Close
X

Cytosorbents Corp CTSO.OQ (NASDAQ Stock Exchange Capital Market)

5.49 USD
+0.18 (+3.39%)
As of Sep 13
Previous Close 5.31
Open 5.41
Volume 31,607
3m Avg Volume 41,806
Today’s High 5.52
Today’s Low 5.26
52 Week High 13.90
52 Week Low 3.68
Shares Outstanding (mil) 32.25
Market Capitalization (mil) 225.74
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 4 analysts

KEY STATS

Revenue (mm, USD)
FY19
5
FY18
23
FY17
15
FY16
10
EPS (USD)
FY19
-0.153
FY18
-0.560
FY17
-0.304
FY16
-0.472
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
33.85
Price to Sales (TTM)
vs sector
9.91
7.90
Price to Book (MRQ)
vs sector
15.03
4.38
Price to Cash Flow (TTM)
vs sector
--
23.70
Total Debt to Equity (MRQ)
vs sector
66.37
17.64
LT Debt to Equity (MRQ)
vs sector
55.27
12.61
Return on Investment (TTM)
vs sector
-78.65
12.69
Return on Equity (TTM)
vs sector
-129.75
17.13

EXECUTIVE LEADERSHIP

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

7 Deerpark Dr Ste K
MONMOUTH JUNCTION   NJ   08852-1977

Phone:

CytoSorbents Corporation is a critical care focused immunotherapy company. The Company is engaged in commercializing its product, CytoSorb, which is a blood purification technology with focus in preventing or treating multiple organ failure. The Company's purification technologies are based on biocompatible, porous polymer beads that remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. The Company's CytoSorb is an extracorporeal cytokine filter and is designed to reduce the cytokine storm that causes inflammation, organ failure and death in common critical illnesses, such as sepsis, burn injury, trauma, lung injury and pancreatitis. In addition, CytoSorb is used in other inflammatory conditions, such as cardiac surgery and autoimmune disease flares and cancer cachexia. It also has other products under development based upon its blood purification technology, including HemoDefend, ContrastSorb, DrugSorb, BetaSorb and others.

SPONSORED STORIES